BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 25273283)

  • 1. Advances in targeting strategies for nanoparticles in cancer imaging and therapy.
    Yhee JY; Lee S; Kim K
    Nanoscale; 2014 Nov; 6(22):13383-90. PubMed ID: 25273283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inorganic nanoparticles for cancer imaging and therapy.
    Huang HC; Barua S; Sharma G; Dey SK; Rege K
    J Control Release; 2011 Nov; 155(3):344-57. PubMed ID: 21723891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of functional quantum dots in cancer diagnosis and therapy: a review].
    Han S; Xia T; Li Q; Guo J; Lu P
    Sheng Wu Gong Cheng Xue Bao; 2013 Jan; 29(1):10-20. PubMed ID: 23631114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional nanoparticles for targeting cancer and inflammatory diseases.
    Jain S; Doshi AS; Iyer AK; Amiji MM
    J Drug Target; 2013 Dec; 21(10):888-903. PubMed ID: 24024598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
    Muthu MS; Singh S
    Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
    Winter PM; Cai K; Caruthers SD; Wickline SA; Lanza GM
    Expert Rev Med Devices; 2007 Mar; 4(2):137-45. PubMed ID: 17359221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-oriented diagnosis and therapy.
    Lin MM; Kim HH; Kim H; Dobson J; Kim DK
    Nanomedicine (Lond); 2010 Jan; 5(1):109-33. PubMed ID: 20025469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
    Talekar M; Kendall J; Denny W; Garg S
    Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theranostic nanomedicine for cancer.
    Sumer B; Gao J
    Nanomedicine (Lond); 2008 Apr; 3(2):137-40. PubMed ID: 18373419
    [No Abstract]   [Full Text] [Related]  

  • 14. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising approaches in using magnetic nanoparticles in oncology.
    Mikhaylov G; Vasiljeva O
    Biol Chem; 2011 Nov; 392(11):955-60. PubMed ID: 21848508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prussian blue nanoparticles and their analogues for application to cancer theranostics.
    Patra CR
    Nanomedicine (Lond); 2016 Mar; 11(6):569-72. PubMed ID: 26911239
    [No Abstract]   [Full Text] [Related]  

  • 17. Nanotechnology advances in brain tumors: the state of the art.
    Invernici G; Cristini S; Alessandri G; Navone SE; Canzi L; Tavian D; Redaelli C; Acerbi F; Parati EA
    Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):58-69. PubMed ID: 21110824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles.
    Gautier J; Allard-Vannier E; Munnier E; Soucé M; Chourpa I
    J Control Release; 2013 Jul; 169(1-2):48-61. PubMed ID: 23567046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics.
    Shi D; Bedford NM; Cho HS
    Small; 2011 Sep; 7(18):2549-67. PubMed ID: 21648074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy.
    Doane TL; Burda C
    Chem Soc Rev; 2012 Apr; 41(7):2885-911. PubMed ID: 22286540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.